Predictive article recommendation using natural language processing and machine learning to support evidence updates in domain-specific knowledge graphs
暂无分享,去创建一个
Gretchen Purcell Jackson | Bhuvan Sharma | Jane L. Snowdon | Kirk A. Beaty | Brett South | Dilhan Weeraratne | Van C. Willis | Claudia S. Huettner | Shang Xue | Vanessa V. Michelini | J. Snowdon | G. Jackson | B. South | Shang Xue | Bhuvan Sharma | K. Beaty | C. Huettner | V. Willis | D. Weeraratne
[1] Yan Wang,et al. Using Machine Learning and Natural Language Processing to Review and Classify the Medical Literature on Cancer Susceptibility Genes , 2019, JCO clinical cancer informatics.
[2] Jia Xu,et al. Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives , 2019, Human Genetics.
[3] Michael McGill,et al. Introduction to Modern Information Retrieval , 1983 .
[4] Ajay K. Royyuru,et al. Comparing sequencing assays and human-machine analyses in actionable genomics for glioblastoma , 2017, Neurology: Genetics.
[5] Laxmi Parida,et al. Watson for Genomics: Moving Personalized Medicine Forward. , 2016, Trends in cancer.
[6] Subha Madhavan,et al. Art and Challenges of Precision Medicine: Interpreting and Integrating Genomic Data Into Clinical Practice. , 2018, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[7] Ajay K. Royyuru,et al. Sequencing and curation strategies for identifying candidate glioblastoma treatments , 2019, BMC Medical Genomics.
[8] Peng Yuan,et al. Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial , 2019, Clinical Cancer Research.
[9] Andrew W. Brown,et al. Analysis of the time and workers needed to conduct systematic reviews of medical interventions using data from the PROSPERO registry , 2017, BMJ Open.
[10] Tao Wang,et al. Effects of icotinib on early-stage non-small-cell lung cancer as neoadjuvant treatment with different epidermal growth factor receptor phenotypes , 2016, OncoTargets and therapy.
[11] Jian Su,et al. Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression , 2018, BMC Cancer.
[12] Alan Ritter,et al. Using ontology-based semantic similarity to facilitate the article screening process for systematic reviews , 2017, J. Biomed. Informatics.
[13] Olivier Bodenreider,et al. Toward an automatic method for extracting cancer- and other disease-related point mutations from the biomedical literature , 2011, Bioinform..
[14] Ronglai Shen,et al. A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers , 2017, Clinical Cancer Research.
[15] Christal D. Sohl,et al. The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMT , 2018, Molecular Cancer Research.
[16] K. Bretonnel Cohen,et al. Text mining for the biocuration workflow , 2012, Database J. Biol. Databases Curation.
[17] Laxmi Parida,et al. Evaluating Clinical Genome Sequence Analysis by Watson for Genomics , 2018, Front. Med..
[18] Yan Li,et al. Effectiveness of EGFR-TKIs in a Patient with Lung Adenocarcinoma Harboring an EGFR-RAD51 Fusion. , 2019, The oncologist.
[19] Peng Yuan,et al. Phase I Study and Biomarker Analysis of Pyrotinib, a Novel Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Won-Ho Shin,et al. Deep learning of mutation-gene-drug relations from the literature , 2017, BMC Bioinformatics.
[21] K. Bretonnel Cohen,et al. MutationFinder: a high-performance system for extracting point mutation mentions from text , 2007, Bioinform..
[22] S. Piantadosi. Zipf’s word frequency law in natural language: A critical review and future directions , 2014, Psychonomic Bulletin & Review.
[23] Siddhartha Jonnalagadda,et al. A new iterative method to reduce workload in systematic review process , 2013, Int. J. Comput. Biol. Drug Des..
[24] Irene Dankwa-Mullan,et al. Clinical insights for hematological malignancies from an artificial intelligence decision-support tool. , 2019, Journal of Clinical Oncology.
[25] Regina Barzilay,et al. Validation of a Semiautomated Natural Language Processing-Based Procedure for Meta-Analysis of Cancer Susceptibility Gene Penetrance. , 2019, JCO clinical cancer informatics.
[26] William R. Hersh,et al. Reducing workload in systematic review preparation using automated citation classification. , 2006, Journal of the American Medical Informatics Association : JAMIA.
[27] Wei Li,et al. Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Nikhil Wagle,et al. The fuzzy world of precision medicine: deliberations of a precision medicine tumor board , 2016, Personalized medicine.
[29] Stan Matwin,et al. A new algorithm for reducing the workload of experts in performing systematic reviews , 2010, J. Am. Medical Informatics Assoc..
[30] Jimmy J. Lin,et al. PubMed related articles: a probabilistic topic-based model for content similarity , 2007, BMC Bioinformatics.
[31] Gerard Salton,et al. A vector space model for automatic indexing , 1975, CACM.
[32] Laxmi Parida,et al. Enhancing Next‐Generation Sequencing‐Guided Cancer Care Through Cognitive Computing , 2017, The oncologist.